NCT04319757 2024-12-05
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Acepodia Biotech, Inc.
Phase 1 Completed
Acepodia Biotech, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)